115 related articles for article (PubMed ID: 26895755)
1. Evaluation of Malignancy Grade of Breast Cancer Using Perflubutane-Enhanced Ultrasonography.
Masumoto N; Kadoya T; Amioka A; Kajitani K; Shigematsu H; Emi A; Matsuura K; Arihiro K; Okada M
Ultrasound Med Biol; 2016 May; 42(5):1049-57. PubMed ID: 26895755
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Region of Interest Drawing for Quantitative Analysis: Differentiation Between Benign and Malignant Breast Lesions on Contrast-Enhanced Sonography.
Nakata N; Ohta T; Nishioka M; Takeyama H; Toriumi Y; Kato K; Nogi H; Kamio M; Fukuda K
J Ultrasound Med; 2015 Nov; 34(11):1969-76. PubMed ID: 26384607
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound imaging of breast tumor perfusion and neovascular morphology.
Hoyt K; Umphrey H; Lockhart M; Robbin M; Forero-Torres A
Ultrasound Med Biol; 2015 Sep; 41(9):2292-302. PubMed ID: 26116159
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasound using real-time contrast harmonic imaging in invasive breast cancer: comparison of enhancement dynamics with three different doses of contrast agent.
Saracco A; Szabó BK; Aspelin P; Leifland K; Tánczos E; Wilczek B; Axelsson R
Acta Radiol; 2015 Jan; 56(1):34-41. PubMed ID: 24445092
[TBL] [Abstract][Full Text] [Related]
5. Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors.
Wan CF; Du J; Fang H; Li FH; Zhu JS; Liu Q
Radiology; 2012 Feb; 262(2):450-9. PubMed ID: 22282183
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Analysis of Contrast-Enhanced Ultrasound Imaging in Invasive Breast Cancer: A Novel Technique to Obtain Histopathologic Information of Microvessel Density.
Mori N; Mugikura S; Takahashi S; Ito K; Takasawa C; Li L; Miyashita M; Kasajima A; Mori Y; Ishida T; Kodama T; Takase K
Ultrasound Med Biol; 2017 Mar; 43(3):607-614. PubMed ID: 28041744
[TBL] [Abstract][Full Text] [Related]
7. Analysis of kinetic curve and model-based perfusion parameters on dynamic contrast enhanced MRI in breast cancer patients: Correlations with dominant stroma type.
Yim H; Kang DK; Jung YS; Jeon GS; Kim TH
Magn Reson Imaging; 2016 Jan; 34(1):60-5. PubMed ID: 26234500
[TBL] [Abstract][Full Text] [Related]
8. Application of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Different Molecular Subtypes of Breast Cancer.
Liang X; Li Z; Zhang L; Wang D; Tian J
Ultrason Imaging; 2020 Nov; 42(6):261-270. PubMed ID: 33019918
[TBL] [Abstract][Full Text] [Related]
9. Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
Koo HR; Cho N; Song IC; Kim H; Chang JM; Yi A; Yun BL; Moon WK
J Magn Reson Imaging; 2012 Jul; 36(1):145-51. PubMed ID: 22392859
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound characteristics of breast cancer: correlation with prognostic factors.
Cao XL; Bao W; Zhu SG; Wang LH; Sun MH; Wang L; Men YM; Xue J
Ultrasound Med Biol; 2014 Jan; 40(1):11-7. PubMed ID: 24207087
[TBL] [Abstract][Full Text] [Related]
11. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy.
Amioka A; Masumoto N; Gouda N; Kajitani K; Shigematsu H; Emi A; Kadoya T; Okada M
Jpn J Clin Oncol; 2016 Apr; 46(4):303-9. PubMed ID: 26848078
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
[TBL] [Abstract][Full Text] [Related]
13. The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer.
Çelebi F; Pilancı KN; Ordu Ç; Ağacayak F; Alço G; İlgün S; Sarsenov D; Erdoğan Z; Özmen V
Diagn Interv Radiol; 2015; 21(6):448-53. PubMed ID: 26359880
[TBL] [Abstract][Full Text] [Related]
14. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic efficacy of contrast-enhanced sonography by combined qualitative and quantitative analysis in breast lesions: a comparative study with magnetic resonance imaging.
Wang L; Du J; Li FH; Fang H; Hua J; Wan CF
J Ultrasound Med; 2013 Oct; 32(10):1805-14. PubMed ID: 24065262
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound.
Saracco A; Szabó BK; Aspelin P; Leifland K; Wilczek B; Celebioglu F; Axelsson R
Acta Radiol; 2012 May; 53(4):382-8. PubMed ID: 22434928
[TBL] [Abstract][Full Text] [Related]
17. Strain elastography for prediction of breast cancer tumor grades.
Grajo JR; Barr RG
J Ultrasound Med; 2014 Jan; 33(1):129-34. PubMed ID: 24371107
[TBL] [Abstract][Full Text] [Related]
18. Perfusion contrast-enhanced ultrasound to predict early lymph-node metastasis in breast cancer.
Mori N; Mugikura S; Miyashita M; Kudo Y; Suzuki M; Li L; Mori Y; Takahashi S; Takase K
Jpn J Radiol; 2019 Feb; 37(2):145-153. PubMed ID: 30460444
[TBL] [Abstract][Full Text] [Related]
19. Breast lesions: imaging with contrast-enhanced subharmonic US--initial experience.
Forsberg F; Piccoli CW; Merton DA; Palazzo JJ; Hall AL
Radiology; 2007 Sep; 244(3):718-26. PubMed ID: 17690324
[TBL] [Abstract][Full Text] [Related]
20. Static and dynamic cumulative maximum intensity display mode for subharmonic breast imaging: a comparative study with mammographic and conventional ultrasound techniques.
Dave JK; Forsberg F; Fernandes S; Piccoli CW; Fox TB; Merton DA; Leodore LM; Hall AL
J Ultrasound Med; 2010 Aug; 29(8):1177-85. PubMed ID: 20660451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
